The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case study
Currently available health economic models for varicella infection are designed to inform the cost-effectiveness of universal varicella vaccination (UVV) compared with no vaccination. However, in countries with an existing UVV program, these models cannot be used to evaluate whether to continue with...
Saved in:
Main Authors: | Stephanie A. Kujawski (Author), Colleen Burgess (Author), Oren Agi (Author), Zohar Attias-Geva (Author), Matthew Pillsbury (Author), David Greenberg (Author), Goran Bencina (Author), Manjiri Pawaskar (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic burden of varicella in Europe in the absence of universal varicella vaccination
by: Manjiri Pawaskar, et al.
Published: (2021) -
Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectiveness.
by: Colleen Burgess, et al.
Published: (2023) -
Correction: Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectiveness.
by: Colleen Burgess, et al.
Published: (2023) -
Estimating the health economic impact of the universal varicella vaccination in Argentina from 2015 to 2019
by: Norberto Giglio, et al.
Published: (2023) -
Varicella vaccination - the global experience
by: Peter Wutzler, et al.
Published: (2017)